Weed (BUDZ) Common Equity (2010 - 2026)
Weed's (BUDZ) quarterly Common Equity came in at -$837527.0 in Q1 2026, down 141.89% year-on-year from $2.0 million in Q1 2025, and down 21.67% quarter-over-quarter from -$688361.0 in Q4 2025.
Weed (BUDZ) Common Equity (2010 - 2026) Analysis & Trends
Weed's Common Equity history runs 13 years deep, the most recent figure standing at -$837527.0 for Q1 2026.
- On a quarterly basis, Common Equity fell 141.89% year-over-year to -$837527.0 in Q1 2026; TTM through Mar 2026 was -$837527.0, a 141.89% decrease from a year earlier, with the FY2025 full-year figure at -$688361.0, down 211.47% from the prior year.
- Common Equity fell to -$837527.0 in Q1 2026 per BUDZ's latest filing, from -$688361.0 in the prior quarter.
- Across five years, Common Equity topped out at $1.2 million in Q2 2022 and bottomed at -$837527.0 in Q1 2026.
- The 5-year median for Common Equity is $1111.0 (2023), against an average of $25489.3.
- Across the five-year window, Common Equity jumped 9573.63% in 2024 and sank 6058.85% in 2025, its largest moves.
- Year by year, Common Equity stood at $169796.0 in 2022, then soared by 50.36% to $255309.0 in 2023, then sank by 186.56% to -$221006.0 in 2024, then tumbled by 211.47% to -$688361.0 in 2025, then dropped by 21.67% to -$837527.0 in 2026.
- Per Business Quant, the three latest BUDZ Common Equity figures stand at -$837527.0 (Q1 2026), -$688361.0 (Q4 2025), and -$519079.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.93 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 8.23 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 3.23 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 47.38 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.90 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 56.13 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 3.41 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.50 Bn |
| 10 | Weed | 3.72 Mn | 3.72 Mn | - | -837,527.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -837,527.00 |
| Dec 31, 2025 | -688,361.00 |
| Sep 30, 2025 | -519,079.00 |
| Jun 30, 2025 | -447,927.00 |
| Mar 31, 2025 | -346,236.00 |
| Dec 31, 2024 | -221,006.00 |
| Sep 30, 2024 | -88,227.00 |
| Jun 30, 2024 | 7,517.00 |
| Mar 31, 2024 | 107,474.00 |
| Dec 31, 2023 | 255,309.00 |
| Sep 30, 2023 | 621,757.00 |
| Jun 30, 2023 | -136,655.00 |
| Mar 31, 2023 | 1,111.00 |
| Dec 31, 2022 | 169,796.00 |
| Sep 30, 2022 | 995,858.00 |
| Jun 30, 2022 | 1.18 Mn |
| Mar 31, 2022 | 379,100.00 |
| Dec 31, 2021 | 617,500.00 |
| Sep 30, 2021 | 800,564.00 |
| Jun 30, 2021 | 851,301.00 |